New Delhi, Jan. 27, 2025 (GLOBE NEWSWIRE) -- According to Astute Analytica’s latest market analysis, the Japan pharmaceutical manufacturing market was valued at US$ 34.7 billion in 2024 and is ...

New Delhi, Jan. 27, 2025 (GLOBE NEWSWIRE) -- According to Astute Analytica’s latest market analysis, the Japan pharmaceutical manufacturing market was valued at US$ 34.7 billion in 2024 and is ...

TOKYO (Kyodo) -- Japanese pharmaceutical company Eisai Co. and U.S. firm Biogen Inc. said Monday that a jointly developed Alzheimer's drug has been approved for continuous use for people with ...

“This initiative will up-level the Japanese pharmaceutical industry with high performance computing and unlock the potential of generative AI to discover new therapies," Makiguchi adde ...

However, only the Japanese pharmaceutical company KM Biologics Co., based in Kumamoto, produces vaccines that can also be given to children. Congo has requested the vaccines from the company.

The Japanese pharmaceutical company Kyowa Kirin Co. plans to sell shares in the Chinese division of the Hong Kong company WinHealth Pharma Group Co. for 15 billion yen ($100 million) as part of the ...

TOKYO -- Japan's Takeda Pharmaceutical announced on Thursday that CEO Christophe Weber will step down in June 2026 and be succeeded by current U.S. business head Julie Kim, who would become the ...

Japan's biggest drugmaker Takeda Pharmaceutical posted third-quarter profits on Thursday that trailed analyst estimates but ...

The Japanese drugmaker said that Kim, president of its U.S. business unit, will succeed Chief Executive Christophe Weber, who ...

Julie Kim, 54, has been running Takeda’s U.S. operations since 2022 and will assume the role of CEO in June next year, ...

Takeda Pharmaceutical said on Thursday its CEO Christophe Weber will retire after 12 years in management at Japan's biggest ...

The Economic Survey 2024-25 says on a global pedestal, India has successfully established itself as one of the top 20 medical ...